Skip to main content
logo
MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
11.00
-0.36 (-3.17%)
Aug 13, 2026, 4:00 PM EDT - Market closed

MiNK Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
5552283788149
Market Cap Growth
12.52%89.97%-25.39%-58.10%-40.82%-
Enterprise Value
45.9944.2927.9733.6568.73110.42
Last Close Price
11.0011.156.9710.7026.1044.60

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
--3.69-1.41-2.05-220.206.28
P/TBV Ratio
-----4.88

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
--0.36-0.25000
Net Debt / Equity Ratio
0.630.57-0.020.1948.93-1.64
Net Debt / EBITDA Ratio
0.740.66-0.030.150.641.38
Net Debt / FCF Ratio
1.291.38-0.040.211.032.97
Quick Ratio
1.161.030.660.301.552.36
Current Ratio
1.231.060.720.321.612.41
Return on Equity (ROE)
80.41%73.90%57.30%243.36%-239.50%200.76%
Return on Assets (ROA)
-100.51%-126.68%-219.76%-176.15%-100.30%-126.61%
Return on Invested Capital (ROIC)
93.58%112.10%98.62%251.64%835.59%-5325.66%
Return on Capital Employed (ROCE)
-736.82%80346.60%279.10%-2365.28%-190.08%-401.98%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-19.52%-13.18%-9.82%-2.04%-29.38%-7.95%
Total Shareholder Return
-19.52%-13.18%-9.82%-2.04%-29.38%-7.95%
SEC Filings: 10-K · 10-Q